Candel Therapeutics Inc. (CADL)

AI Score

Unlock

4.70

-0.55 (-10.48%)

At close: Apr 04, 2025, 2:52 PM

Dividends

No dividend history available for Candel Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

CADL News

2 days ago · Candel Therapeutics reveals new data showing better outcomes for glioma patients using CAN-2409 - proactiveinvestors.com
5 days ago · Candel Therapeutics reports breakthrough data for late-stage lung cancer – ICYMI - proactiveinvestors.com
1 week ago · Candel Therapeutics reports positive survival data for CAN-2409 in advanced lung cancer trial - proactiveinvestors.com
1 week ago · Bears are Losing Control Over Candel Therapeutics (CADL), Here's Why It's a 'Buy' Now - zacks.com
2 weeks ago · Candel Therapeutics partners with IDEA Pharma on commercialization of lead asset CAN-2409 - proactiveinvestors.com
2 weeks ago · Candel Therapeutics appoints cancer immunology expert to research advisory board - proactiveinvestors.com
3 weeks ago · Candel Therapeutics eyes CAN-2409 BLA filing, advances cancer pipeline - proactiveinvestors.com
1 month ago · Candel Therapeutics CEO discusses promising Phase 2 pancreatic cancer trial results - ICYMI - proactiveinvestors.com
1 month ago · Candel Therapeutics: I Say Stay The Course Despite The Market's Rebuke Of Positive Pancreatic Data - seekingalpha.com
1 month ago · Candel Therapeutics reports significant survival benefit for pancreatic cancer therapy - proactiveinvestors.com